Perioperative use of gabapentinoids in France. Mismatch between clinical practice and scientific evidence - Archive ouverte HAL Access content directly
Journal Articles Anaesthesia Critical Care & Pain Medicine Year : 2018

Perioperative use of gabapentinoids in France. Mismatch between clinical practice and scientific evidence

(1, 2, 3) , (4) , (5) , (6, 7)
1
2
3
4
5
6
7

Abstract

Background - Gabapentinoids have governmental health agency approval for "chronic neuropathic pain." Over the last decade, however, the perioperative prescription of gabapentinoids has become more popular among anaesthesiologists due to their anxiolytic and antihyperalgesic proprieties, despite weak scientific evidence supporting the risk/benefit ratio for this indication.

Methods - Our aim was to extensively describe the use of perioperative gabapentinoids by French anaesthesiologists. An online questionnaire was sent to the French Society of Anaesthesiology members. The questionnaire, focusing on gabapentinoid prescriptions, included questions on demographic data, patient conditions and types of surgeries, mode of prescription, motives and presumed side effects (dizziness, confusion, desaturation and visual disorders).

Results - Five hundred and eight questionnaires were analysed, among which 70% reported gabapentinoid use. Twenty-five percent of prescribers stated using gabapentinoids in all types of surgeries, 30% in outpatient surgeries and 46% in combination with regional anaesthesia. In 66% of the cases, preoperative and postoperative prescriptions were combined. Sedation, dizziness and visual disturbance were expected side effects according to 68%, 45% and 20% of anaesthesiologists, respectively. Reported reasons in favor of gabapentinoid prescription were prevention of chronic pain (93%), expected high postoperative acute pain, i.e. painful surgeries (91%), a history of chronic pain (72%) and patient opioid dependence (72%).

Discussion - French anaesthesiologists have recently included gabapentinoids in the multimodal management of postoperative pain but they are unaware of certain frequent side effects. Moreover, their expectations about the prevention of chronic pain are not validated. Our survey is a call to moderate the systematic prescription of these drugs in the perioperative period.

Fichier principal
Vignette du fichier
Martinez et al. - Perioperative use of gabapentinoids in France.pdf (722.58 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01709942 , version 1 (16-05-2018)

Identifiers

Cite

Valeria Martinez, Michel Carles, Emmanuel Marret, Hélène Beloeil. Perioperative use of gabapentinoids in France. Mismatch between clinical practice and scientific evidence. Anaesthesia Critical Care & Pain Medicine, 2018, 37 (1), pp.43-47. ⟨10.1016/j.accpm.2017.01.010⟩. ⟨hal-01709942⟩
189 View
238 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More